MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/lary.26140

Медицинская библиотека · The Laryngoscope · 2016

Randomized controlled trial of a bioabsorbable steroid-releasing implant in the frontal sinus opening.

Smith Timothy L, Singh Ameet, Luong Amber, Ow Randall A, Shotts Steven D, Sautter Nathan B, Han Joseph K, Stambaugh James, Raman Aarthi

СтатьяМногоцентровое исследованиеРандомизированное исследованиеПоддержка исследования: вне правительства СШАПеревод пока не подготовлен

Аннотация

OBJECTIVES/HYPOTHESIS: To assess safety and efficacy of a steroid-releasing implant in improving surgical outcomes when placed in the frontal sinus opening (FSO) following endoscopic sinus surgery (ESS) in patients with chronic rhinosinusitis (CRS).

STUDY

DESIGN

Prospective, multicenter, randomized, blinded trial using an intrapatient control design.

METHODS

Eighty adult (≥ 18 years) CRS patients who underwent successful bilateral frontal sinusotomy were randomized to receive a steroid-releasing implant in one FSO, whereas the contralateral control side received no implant. All patients received standard postoperative care. Endoscopic evaluations recorded at 30-days postendoscopic sinus surgery (ESS) were graded real time by clinical investigators and by an independent, blinded sinus surgeon to assess the need for postoperative interventions in the FSO.

RESULTS

Implants were successfully placed in all 80 frontal sinuses, resulting in 100% implant delivery success. At 30-days post-ESS, steroid-releasing implants provided a statistically significant (P = 0.0070) reduction in the need for postoperative interventions compared to surgery alone by an independent reviewer, representing 38% relative reduction. Clinical investigators reported statistically significant reduction in this measure at 30 days (P < 0.0001) and 90 days (P = 0.0129). Clinical investigators also reported a 55.6% reduction in the need for oral steroid interventions (P = 0.0015), 75% reduction in the need for surgical interventions (P = 0.0225), 16.7% reduction in inflammation score, 54.3% reduction in restenosis rate (P = 0.0002), and 32.2% greater diameter of FSO (P < 0.0001) on treated sides compared to control at 30 days. No implant-related adverse events were reported.

CONCLUSION

This study demonstrates the efficacy of steroid-releasing implants in improving outcomes of frontal sinus surgery.

LEVEL OF EVIDENCE: 1b. Laryngoscope, 126:2659-2664, 2016.

Для цитирования: Smith Timothy L, Singh Ameet, Luong Amber, Ow Randall A, Shotts Steven D, Sautter Nathan B, Han Joseph K, Stambaugh James, Raman Aarthi. Randomized controlled trial of a bioabsorbable steroid-releasing implant in the frontal sinus opening.. The Laryngoscope. 2016. DOI: 10.1002/lary.26140.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.